Major Cancer Research Center Signs New $3.5 Million, Multiyear Commitment to OmniComm's TrialMaster® EDC

Stock Information for OmniComm Systems Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About OmniComm Systems Inc

Global CRO Signs Seven-Year TrialOne® Agreement With OmniComm Systems
Sorrento Therapeutics Selects OmniComm's TrialMaster® EDC for Cancer Research
Global Contract Research Organization Announces $7.8 Million Extension Agreement for OmniComm's TrialOne®
Bob Schweitzer Joins Envision Solar International as Independent Director and Chair of the Audit Committee
Large Pharmaceutical Company in China Selects TrialMaster® EDC and Acuity Analytics for Major Clinical Study
OmniComm Systems, Inc. Reports Financial Results for the Quarter and Year-to-Date Period Ending June 30, 2018
OmniComm Opens New Office in Bengaluru, India to Expand International Presence
OmniComm Attracts Record Crowd for European Innovation Forum 2018

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.